---
title: "Apex Critical Metals tumbles 19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304640068.md"
description: "Apex Critical Metals fell 19.38% to US$3.120. Down 48.18% over ten sessions and down 61.53% from IPO price."
datetime: "2026-11-06T18:26:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304640068.md)
  - [en](https://longbridge.com/en/news/304640068.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304640068.md)
generator: "portal-rs"
---

# Apex Critical Metals tumbles 19%

Apex Critical Metals (APXC.US) tumbled more than **19%** during regular trading to **$3.12**.

The stock is down 48.18% over the past ten sessions and down 61.53% from its IPO price. It sits 64.90% below its 52-week high of US$8.890. The intraday swing reached 13.44%.

The Nasdaq Composite is down 3.40% over the past five sessions and up 5.72% year to date.

The company issued 60,000 American depositary shares at $4.65 each, completing the full exercise of the underwriters' over-allotment option in its public offering. Separately, Apex set the exercise price for representative warrants at $5.81 per ADS, with an expiration date of Oct. 23, 2030.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [APXC.US](https://longbridge.com/en/quote/APXC.US.md)

## Related News & Research

- [Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift | APXC Stock News](https://longbridge.com/en/news/304997284.md)
- [Apex Critical Metals Completes Nasdaq Listing](https://longbridge.com/en/news/303120891.md)
- [‘The Time Has Come,’ Says Top Investor About Rocket Lab Stock](https://longbridge.com/en/news/305860342.md)
- [Nvidia has lost $2 trillion in value. Here's what options traders expect from earnings](https://longbridge.com/en/news/305815593.md)
- [BREAKINGVIEWS-Nine questions for Nvidia’s stand-in CEO](https://longbridge.com/en/news/305850075.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**